These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17399968

  • 21. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 22. Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function.
    Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H, Tamura Y.
    Int J Cardiol; 2008 Mar 28; 125(1):136-8. PubMed ID: 17400311
    [Abstract] [Full Text] [Related]

  • 23. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
    Broncel M, Bała A, Koter-Michalak M, Duchnowicz P, Wojsznis W, Chojnowska-Jezierska J.
    Wiad Lek; 2007 Mar 28; 60(7-8):321-8. PubMed ID: 18175550
    [Abstract] [Full Text] [Related]

  • 24. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
    Azar RR, Badaoui G, Sarkis A, Azar M, Aydanian H, Harb S, Achkouty G, Kassab R.
    Am J Cardiol; 2010 Jul 15; 106(2):193-7. PubMed ID: 20599002
    [Abstract] [Full Text] [Related]

  • 25. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
    Dogra GK, Watts GF, Chan DC, Stanton K.
    Diabet Med; 2005 Mar 15; 22(3):239-42. PubMed ID: 15717868
    [Abstract] [Full Text] [Related]

  • 26. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients.
    Sardo MA, Campo S, Bonaiuto M, Bonaiuto A, Saitta C, Trimarchi G, Castaldo M, Bitto A, Cinquegrani M, Saitta A.
    Curr Med Res Opin; 2005 May 15; 21(5):777-84. PubMed ID: 15969877
    [Abstract] [Full Text] [Related]

  • 27. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun 15; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 28. Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus.
    Shimabukuro M, Higa M, Tanaka H, Shimabukuro T, Yamakawa K, Masuzaki H.
    Diabet Med; 2011 Jul 15; 28(7):856-64. PubMed ID: 21244474
    [Abstract] [Full Text] [Related]

  • 29. Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.
    Athyros VG, Kakafika AI, Papageorgiou AA, Paraskevas KI, Tziomalos K, Anagnostis P, Pagourelias E, Koumaras C, Karagiannis A, Mikhailidis DP.
    Curr Med Res Opin; 2008 Jun 15; 24(6):1593-9. PubMed ID: 18430270
    [Abstract] [Full Text] [Related]

  • 30. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
    Sang ZC, Wang F, Zhou Q, Li YH, Li YG, Wang HP, Chen SY.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1615-20. PubMed ID: 19719960
    [Abstract] [Full Text] [Related]

  • 31. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia.
    Paragh G, Törocsik D, Seres I, Harangi M, Illyés L, Balogh Z, Kovács P.
    Curr Med Res Opin; 2004 Aug 20; 20(8):1321-7. PubMed ID: 15324535
    [Abstract] [Full Text] [Related]

  • 32. Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia.
    Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M.
    Kardiol Pol; 2004 May 20; 60(5):454-8. PubMed ID: 15247960
    [Abstract] [Full Text] [Related]

  • 33. Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial.
    Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB.
    Am Heart J; 2006 Nov 20; 152(5):982.e1-5. PubMed ID: 17070175
    [Abstract] [Full Text] [Related]

  • 34. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T, Akar Bayram N, Kayhan T, Canbay A, Sahin D, Durmaz T, Ozdemir O, Aydoğdu S, Diker E.
    Anadolu Kardiyol Derg; 2008 Dec 20; 8(6):407-12. PubMed ID: 19103535
    [Abstract] [Full Text] [Related]

  • 35. Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin.
    Ozsoy RC, van der Steeg WA, Kastelein JJ, Arisz L, Koopman MG.
    Nephrol Dial Transplant; 2007 Jun 20; 22(6):1578-86. PubMed ID: 17347284
    [Abstract] [Full Text] [Related]

  • 36. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
    Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA, Vascular Basis Study Group.
    Circulation; 2005 Apr 12; 111(14):1747-55. PubMed ID: 15809368
    [Abstract] [Full Text] [Related]

  • 37. Effect of atorvastatin on impaired vascular function in healthy old men.
    Weverling-Rijnsburger AW, Blauw GJ, Meinders AE.
    J Clin Pharm Ther; 2004 Apr 12; 29(2):157-64. PubMed ID: 15068405
    [Abstract] [Full Text] [Related]

  • 38. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
    Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D.
    Am J Cardiol; 2007 Jun 15; 99(12):1706-1713. PubMed ID: 17560879
    [Abstract] [Full Text] [Related]

  • 39. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
    Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, Di Sciascio G, Covino E.
    Eur J Cardiothorac Surg; 2005 Dec 15; 28(6):805-10. PubMed ID: 16274999
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA, Bays H, Conard S, Bird S, Rubino J, Hanson ME, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1495-501. PubMed ID: 19026303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.